Antioxidant Supplements and Breast Cancer: A Systematic Review and Meta-Analysis
Journal Title: International Journal of Cancer Management - Year 2018, Vol 11, Issue 4
Abstract
Context: Breast cancer is the second most common type of cancer worldwide and the most frequent one among women. Some studies suggest a favorable role of antioxidants on breast cancer, but this is still controversial. Objectives: The main objective of this article was to determine the safety and efficacy of antioxidant supplements on breast cancer. Data Sources: In order to gather evidence, main databases (MEDLINE, PubMed, Cochrane Library, Science Direct, Trip, Google Scholar, Institute of Scientific Information (ISI), SCOPUS, and EMBASE) as well as relevant websites were searched without time limit up to November 2016. We searched with appropriate keywords and strategies. After the quality assessment of studies, study data were extracted by 2 reviewers. Because all the outcomes were dichotomous, relative risk by using the fixed-effects model proposed by Mantel-Hanzel was used in the meta-analysis. I² values were used for the evaluation of heterogeneity. Analyses were conducted, using review manager and CMA Software. Results: Out of 825 studies, 652 studies were entered firstly and 14 RCTs were selected after the final review. There was not significant difference between Antioxidant and Placebo group in breast cancer incidence (P = 0.88), quality of life (P = 0.79), daily hot-flash score (P = 0.87) and toxicity such as nausea-vomiting (P = 0.87), diarrhea (P = 0.17), constipation (P = 0.35), fatigue (P = 0.14), alopecia (P = 0.22), anemia (P = 0.67), headaches (P = 0.73), leukopenia (P = 0.2), and Neutropenia (P = 0.08). Conclusions: The results of our meta-analysis do not support the effectiveness of antioxidants in reducing the risk of breast cancer. Also, this study showed that there is no sufficient clinical evidence to support the effectiveness of these supplements during the treatment of patients with breast cancer. It is recommended that clinician do not emphasize on these supplements in breast cancer treatment.
Authors and Affiliations
Mohammad Moradi-Joo, Saeed Heidari, Maryam Seyed-Nezhad, Mohammad Esmaeil Akbari, Ahmad Moosavi, Sayed Hossein Davoodi
Keywords
Related Articles
- EP ID EP365688
- DOI 10.5812/ijcm.10082.
- Views 78
- Downloads 0
Immunohistochemical Study of HER2/neu Expression in Colorectal Cancer and its Relation to other Clinicopathological Criteria and Prognostic Factors
Background: Human epidermal growth factor receptor 2 (HER2) overexpression and amplification have been studied as a therapeutic and prognostic target in a number of tumors although conflicting data exist about the incide...
Applying Bioinformatic Tools for Modeling and Modifying Type II <i>E. coli</i> l-Asparginase to Present a Better Therapeutic Agent/Drug for Acute Lymphoblastic Leukemia
Background Asparginase is known to be one of the most important bedrocks of acute lymphoblastic leukemia (ALL) treatment in almost all pediatric regimens in treatment protocols. <...
Spatial Clustering of Breast Cancer: An Epidemiological Analysis of Iranian Women
Background: Breast cancer is the most common cancer among women in Iran. The aim of this study was to explore the spatial autocorrelation and the estimation incidence rates variance among Iranian provinces. Methods: In t...
Cannabis sativa Extract Reduces Cytoskeletal Associated Proteins in Breast Cancer Cell Line
Background: Previous studies suggested that Cannabis sativa has anti-cancer properties influencing tumor size and metastasis properties. Microtubule associated proteins (MAPs) such as tau binds to the microtubules and le...
Anti-Proliferative Effects of Piroxicam and Nimesulide on A431 Human Squamous Carcinoma Cell Line
Background Skin cancer is one of the most common types of cancer worldwide and non-steroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a...